CHARLES SCHWAB INVESTMENT MANAGEMENT INC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 133 filers reported holding KARUNA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 3.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$36,918,941
-8.4%
218,339
+17.5%
0.01%
-8.3%
Q2 2023$40,288,778
-11.7%
185,791
-26.0%
0.01%
-14.3%
Q1 2023$45,607,624
+0.4%
251,088
+8.7%
0.01%
-6.7%
Q4 2022$45,404,665
-7.2%
231,067
+6.2%
0.02%
-16.7%
Q3 2022$48,926,000
+125.7%
217,515
+26.9%
0.02%
+125.0%
Q2 2022$21,678,000
+6.6%
171,347
+6.8%
0.01%
+33.3%
Q1 2022$20,336,000
-0.5%
160,391
+2.8%
0.01%0.0%
Q4 2021$20,444,000
+9.3%
156,059
+2.1%
0.01%0.0%
Q3 2021$18,701,000
+19.6%
152,873
+11.4%
0.01%
+20.0%
Q2 2021$15,642,000
+7.6%
137,216
+13.5%
0.01%0.0%
Q1 2021$14,531,000
+33.5%
120,857
+12.8%
0.01%
+25.0%
Q4 2020$10,888,000
+33.5%
107,172
+1.6%
0.00%0.0%
Q3 2020$8,154,000
-9.0%
105,453
+31.2%
0.00%0.0%
Q2 2020$8,958,000
+90.2%
80,363
+22.9%
0.00%
+33.3%
Q1 2020$4,710,000
+43.4%
65,406
+50.1%
0.00%
+50.0%
Q4 2019$3,284,000
+523.1%
43,584
+35.1%
0.00%
Q3 2019$527,00032,2550.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$169,578,43555.90%
Nan Fung Group Holdings Ltd 225,688$48,940,44331.28%
Sofinnova Investments, Inc. 1,381,149$299,502,16119.62%
Paradigm Biocapital Advisors LP 283,605$61,499,7444.75%
First Light Asset Management, LLC 208,746$45,266,5703.55%
Avidity Partners Management LP 442,200$95,891,0703.35%
CATALYST PRIVATE WEALTH, LLC 21,837$4,735,3532.97%
Rock Springs Capital Management LP 493,527$107,021,3302.55%
Boxer Capital, LLC 250,000$54,2132.51%
DAFNA Capital Management LLC 42,173$9,145,2152.50%
View complete list of KARUNA THERAPEUTICS INC shareholders